CDMO News

• WACKER and CordenPharma Achieve Pandemic Readiness in June 2024

  23 June 2024

  CDMOPharma

  

  The consortium will produce 80 million mRNA vaccine doses annually if needed, following a successful expansion and qualification phase, ensuring pandemic readiness for at least five years.
• Merck Invests €62M in New Quality Control Facility

  11 June 2024

  SpecialtiesCDMOPharma

  

  The new 10,000 sqm facility in Darmstadt will house 135 employees, meet sustainability standards, and enhance quality control for life science products, supporting Merck's €1.5B investment program.
• WACKER Launches mRNA Center in Halle, Germany

  3 June 2024

  CDMOPharma

  

  The new facility in Halle enables large-scale mRNA production, creating over 100 jobs and supporting Germany's pandemic preparedness with a capacity for 200 million vaccine doses annually.
• Pantherna and WACKER Expand mRNA Biopharmaceutical Collaboration

  5 April 2024

  CDMOPharma

  

  WACKER's Halle site will produce mRNA-based ARDS treatment using a scalable process. The facility, operational by mid-2024, marks a milestone in their collaboration with Pantherna.
• PanTera and Bayer Sign Actinium-225 Supply Agreement

  13 February 2024

  CDMOPharma

  

  Starting in late 2024, PanTera will supply actinium-225, enhancing access for clinical trials and developing a large-scale production facility to meet global demand for radiopharma-based cancer treatments.

• Novo Nordisk to Invest €2.1bn in Danish Manufacturing Expansion

  12 June 2023

  CDMOPharma

  

  The €2.1bn investment will expand API production in Hillerød, creating 340 jobs by 2029. The facility will enhance production capacity, flexibility, and sustainability for future chronic disease treatments.
• WACKER Acquires ADL Biopharma to Boost Biotechnology Business

  8 May 2023

  SpecialtiesCDMOPharmaFood

  

  The acquisition expands fermentation capacity by 2,000 cubic meters, enhances recovery and purification processes, and aims to grow customer relationships in food, pharmaceutical, and consumer goods sectors.
• Lonza Expands Drug Product Manufacturing in Visp

  29 March 2023

  CDMOPharma

  

  The new cGMP line in Visp is operational, with first batches in April 2023. It supports clinical and commercial needs, enhancing end-to-end solutions and complementing recent site expansions.
• Sandoz to Build New Biologics Plant in Slovenia

  9 March 2023

  CDMOPharma

  

  The $400M investment aims to boost biosimilar production, with operations starting in 2026. This supports the company's growth in biosimilars and antibiotics, enhancing access to critical medicines.
• Lonza Expands Bioconjugation Facility in Visp

  16 February 2023

  CDMOPharma

  

  The expansion includes two new manufacturing suites, enhancing capabilities for clinical and commercial supply, and increasing process, analytical development, and quality control capacity.
• Lonza to Build Large-Scale Drug Product Facility in Stein

  1 July 2022

  CDMOPharma

  

  The CHF 500M facility, set for 2026 completion, will enhance end-to-end drug product manufacturing, leveraging existing infrastructure and focusing on sustainability with a photovoltaic roof.
• Arxada Invests CHF 20m in Czech Biotech Plant

  18 November 2021

  CDMO

  

  The investment will enhance infrastructure, expand technological options, and increase formulation capacity to support a growing customer base and accelerate project development.
• Eurofins Expands Chemistry Capacity for Drug Discovery Market

  24 August 2020

  SpecialtiesCDMOPharma

  

  A new 63,000 sq ft facility in Murcia, Spain, will double current capacity for chemical synthesis and purification, supporting growth and providing new services. Completion is expected by early 2021.
• WACKER Expands Amsterdam Biotech Facility

  28 July 2020

  CDMOPharma

  

  Investing in new fermentation lines and cleanroom upgrades, the Amsterdam site will enhance production of biologics, LMPs, and vaccines, supporting growth in the pharmaceutical market.
• AGC Expands Spanish Pharmaceutical Production

  7 April 2020

  CDMOPharma

  

  The expansion will boost production capacity by 1.3 times and add a new R&D facility. This aligns with AGC's strategy to grow its life-sciences business and meet rising demand in the pharmaceutical CDMO market.
• WeylChem Invests in Allessa Multi-Purpose Plant

  4 February 2020

  Base chemistrySpecialtiesCDMO

  

  WeylChem is upgrading its Frankfurt Fechenheim plant to enhance its HALEX technology, driven by customer demand. The new plant will be operational in H2 2021, alongside a new SAP S/4 Hana system.
• WuXi Vaccines to Invest $240M in New Ireland Facility

  22 November 2019

  CDMOPharma

  

  The new facility in Dundalk will create 200 jobs, produce vaccines for a global pharma, and enhance Ireland's life sciences ecosystem, pending planning approval.
• Merz and Oncotec Invest in Dessau BioPharmaPark

  11 September 2019

  CDMOPharma

  

  Merz opens a new filler plant, while Oncotec unveils a robot-controlled filling line and visual inspection system, marking significant investments and expansions at Dessau BioPharmaPark.
• Merck Expands Biotech Manufacturing Capacity

  28 March 2019

  SpecialtiesCDMOPharma

  

  €150M investment in Aubonne, Switzerland, for new building with advanced tech to boost production of biotech medicines, meeting global demand. Completion expected by 2023.
• Cerbios Expands High Potency API Manufacturing

  14 January 2019

  CDMOPharma

  

  A new production line for larger volumes and batch sizes will be added, enhancing capacity for HPAIs and CDMO services, with completion expected in the second half of 2020.
• Almac Group Adopts Continuous Flow Technology

  8 January 2019

  CDMOPharma

  

  The company expands its API services with continuous flow technology, enhancing product quality, process safety, and efficiency. A 4-year strategy focuses on advanced synthesis methods.
• WACKER Upgrades Jena Biotech Facility

  13 September 2018

  CDMOPharma

  

  New equipment enhances biopharmaceutical production in Jena. ANVISA inspection confirms high quality standards, boosting site appeal and customer benefits.
• AGC Biologics Expands Copenhagen Facility

  22 August 2018

  CDMOPharma

  

  The facility will add a 6Pack™ suite with six 2000L bioreactors, enhancing flexible cGMP production. New capabilities include harvesting, purification, and media production, operational by November 2018.
• New Tablet Production Facility in Ingelheim for Global Drug Launches

  21 August 2018

  CDMOPharma

  

  The new facility will develop and produce innovative tablet drugs for global markets, focusing on complex production technologies and maintaining the value chain in Germany.
• Boehringer Ingelheim invests €65M in avian vaccines

  11 April 2018

  CDMOPharma

  

  A new 5,700 sq m facility in Lyon will boost avian vaccine production, creating 42 jobs. The environmentally friendly site will triple inactivated vaccine capacity by 2020.
• Saltigo Marks 50 Years of Innovation

  29 November 2017

  SpecialtiesCDMO

  

  ZeTO celebrates 50 years with a €60M expansion, adding new production lines and storage. Investments total €300M over 11 years, enhancing capacity and maintaining cutting-edge operations.
• Fresenius Kabi Expands Portugal Plant

  6 July 2017

  CDMOPharma

  

  Two new antibiotic production lines added, creating 80 jobs with a €17 million investment. The plant now spans 6,000 square meters and employs around 600 people.